A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood ...
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian ...
Stocktwits on MSN
IBRX stock can't shake FDA delay overhang: Founder touts Saudi and Greece progress with Anktiva as bright spots
Soon-Shiong highlighted that ImmunityBio’s Quilt 3005 immunotherapy is already approved by the Saudi FDA. ・Investors are closely watching the FDA’s ongoing review of ImmunityBio’s resubmitted BLA for ...
There is a classic image in cancer treatment of a patient triumphantly ringing a bell to commemorate the end of chemotherapy ...
Indias cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through ...
Trying pollen seasons are becoming the norm in Western Pennsylvania. In March, TribLive reported that allergy season is ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company') announced that the sNDA (the 'Application') for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also ...
Vietnam’s Ministry of Health is considering adding 84 medicines, including 30 cancer treatment drugs, to the list of ...
Recurrent breast cancer remains a major clinical challenge, accounting for the majority of breast cancer–related mortality despite significant advances in ...
A research team led by the University of Michigan College of Pharmacy and the University of Texas MD Anderson Cancer Center ...
How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...
The company will submit an updated dataset with additional patients, longer follow up, and supportive data from the ALLELE study to support its BLA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results